Shares of InVitae Corp (NASDAQ:NVTA) were up 8.5% during trading on Monday . The stock traded as high as $8.39 and last traded at $8.21, with a volume of 60,202 shares. The stock had previously closed at $7.57.

Several analysts have commented on NVTA shares. Zacks Investment Research upgraded shares of InVitae Corp from a “sell” rating to a “hold” rating in a report on Tuesday, August 23rd. Benchmark Co. started coverage on shares of InVitae Corp in a report on Thursday, June 30th. They issued a “hold” rating and a $8.50 price objective for the company. Finally, JPMorgan Chase & Co. raised their price objective on shares of InVitae Corp from $12.00 to $14.00 and gave the stock an “overweight” rating in a report on Tuesday, August 9th.

The company has a 50 day moving average of $8.53 and a 200 day moving average of $8.89. The company’s market capitalization is $265.22 million.

InVitae Corp (NASDAQ:NVTA) last released its quarterly earnings data on Monday, August 8th. The company reported ($0.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by $0.01. The business had revenue of $5.60 million for the quarter, compared to the consensus estimate of $5.81 million. InVitae Corp’s revenue for the quarter was up 211.1% compared to the same quarter last year. During the same period last year, the business posted ($0.76) earnings per share. Equities research analysts anticipate that InVitae Corp will post ($2.96) EPS for the current fiscal year.

Invitae Corporation (Invitae) utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.